Table 2 Standardized incidence ratios (SIRs) of second primary malignancies (SPMs) by latency period after the diagnosis of chronic lymphocytic leukemia (CLL), patient age, and race over time

1.61^a (1.2–2.11)

1.19 (0.9–1.54)

1.54^a (1.23–1.89)

1.79^a (1.52–2.08)

1.26 (0.96–1.64)

1.04 (0.8–1.31)

1.02 (0.81–1.26)

1.44^a (1.24–1.67)

1.30^a (1.18–1.44)

1.17^a (1.08–1.28)

1.14^a (1.06–1.24)

1.30^a (1.22–1.39)

1.11 (0.99–1.25)

1.07 (0.97–1.17)

1.22^a (1.13–1.32)

1.34^a (1.22–1.46)

1.08 (0.97–1.2)

1.05 (0.96–1.15)

1.18^a (1.08–1.29)

1.41^a (1.07–1.82)

1.53^a (1.17–1.97)

1.31^a (1.02–1.67)

1.52^a (1.21–1.87)

2.14^a (1.6–1.79)

1.18^a (1.10–1.26)

1.10^a (1.04–1.16)

1.19^a (1.13–1.25)

1.37^a (1.3–1.44)

1.12 (0.93–1.34)

1.02 (0.87–1.19)

1.04 (0.9–1.2)

1.26^a (1.13–1.4)

1.19^a (1.12–1.26)

1.08^a (1.03–1.14)

1.17^a (1.12–1.23)

1.36^a (1.3–1.43)

1.27 (0.97–1.65)

1.47^a (1.18–1.81)

1.49^a (1.21–1.8)

1.46^a (1.21–1.75)

1.02 (0.33–2.38)

1.62^a (1.01–2.45)

1.41 (0.99–1.95)

2.07^a (1.55–2.72)